Susquehanna International Group Portfolio holdings
Susquehanna International Group (SIG), founded in 1987 by Jeff Yass and a group of friends, is a privately held global quantitative trading and technology firm headquartered in Bala Cynwyd, Pennsylvania. Specializing in trading equities, fixed income, commodities, derivatives, and ETFs, SIG has grown into a major market maker, handling around 600 equity options and 45 index options across exchanges like the CBOE, while employing over 3,000 people worldwide. The firm leverages a data-driven, probabilistic approach—rooted in the founders’ poker-playing days—to provide liquidity and competitive pricing in financial markets, with additional ventures in private equity, venture capital (notably an early investment in ByteDance, TikTok’s parent company), and sports betting analytics. Known for its innovative culture and use of game theory, SIG operates offices across North America, Europe, Asia, and Australia, maintaining a low-profile yet influential presence in global finance.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$892M |
| 2 |
Bank of America
BAC
|
+$350M |
| 3 |
Intel
INTC
|
+$242M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$227M |
| 5 |
AB InBev
BUD
|
+$192M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.99B |
| 2 |
Amazon
AMZN
|
+$940M |
| 3 |
Air Products & Chemicals
APD
|
+$223M |
| 4 |
WFT
Weatherford International plc
WFT
|
+$206M |
| 5 |
Mondelez International
MDLZ
|
+$192M |
Sector Composition
| 1 | Healthcare | 11.09% |
| 2 | Technology | 10.64% |
| 3 | Consumer Discretionary | 10.26% |
| 4 | Financials | 9.63% |
| 5 | Communication Services | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
CoreCivic
CXW
$2.16B
| $9.14M | ﹤0.01% |
291,000
-75,722
| -21% | -$2.38M |
|
277
MSC Industrial Direct
MSM
$5.08B
| $9.13M | ﹤0.01% |
88,801
+63,501
| +251% | +$6.53M |
|
278
Schwab Emerging Markets Equity ETF
SCHE
$11B
| $9.11M | ﹤0.01% |
379,879
-110,150
| -22% | -$2.64M |
|
|
ETFC
279
DELISTED
E*Trade Financial Corporation
ETFC
| $9.05M | ﹤0.01% |
259,494
+124,578
| +92% | +$4.35M |
|
280
Huntington Ingalls Industries
HII
$10.7B
| $8.98M | ﹤0.01% |
44,856
+28,656
| +177% | +$5.74M |
|
281
Kraft Heinz
KHC
$31.4B
| $8.93M | ﹤0.01% |
+98,299
| New | +$8.93M |
|
282
BioMarin Pharmaceuticals
BMRN
$10.5B
| $8.91M | ﹤0.01% |
101,540
-223,449
| -69% | -$19.6M |
|
283
abrdn Physical Gold Shares ETF
SGOL
$5.81B
| $8.85M | ﹤0.01% |
730,620
+210,210
| +40% | +$2.55M |
|
284
Barclays
BCS
$71.8B
| $8.83M | ﹤0.01% |
826,035
-18,194
| -2% | -$195K |
|
285
Nutanix
NTNX
$20.5B
| $8.8M | ﹤0.01% |
+468,877
| New | +$8.8M |
|
|
INFO
286
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $8.79M | ﹤0.01% |
209,495
+64,233
| +44% | +$2.69M |
|
|
CIT
287
DELISTED
CIT Group Inc.
CIT
| $8.71M | ﹤0.01% |
+202,913
| New | +$8.71M |
|
288
Williams Companies
WMB
$71.4B
| $8.71M | ﹤0.01% |
294,213
-197,223
| -40% | -$5.84M |
|
289
Exact Sciences
EXAS
$10.3B
| $8.65M | ﹤0.01% |
366,330
+53,510
| +17% | +$1.26M |
|
290
TripAdvisor
TRIP
$2.06B
| $8.63M | ﹤0.01% |
199,970
+116,184
| +139% | +$5.01M |
|
291
Take-Two Interactive
TTWO
$45.2B
| $8.52M | ﹤0.01% |
143,726
+60,839
| +73% | +$3.61M |
|
|
ARCH
292
DELISTED
Arch Resources, Inc.
ARCH
| $8.5M | ﹤0.01% |
123,270
-587
| -0.5% | -$40.5K |
|
|
IBDK
293
DELISTED
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
| $8.48M | ﹤0.01% |
339,650
+311,376
| +1,101% | +$7.78M |
|
294
Gartner
IT
$17.6B
| $8.47M | ﹤0.01% |
78,411
+69,446
| +775% | +$7.5M |
|
295
Alnylam Pharmaceuticals
ALNY
$61.4B
| $8.46M | ﹤0.01% |
164,998
+25,827
| +19% | +$1.32M |
|
|
OIL
296
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes Linked to Goldman Sachs Crude Oil Total Return In
OIL
| $8.42M | ﹤0.01% |
1,508,028
-292,874
| -16% | -$1.63M |
|
297
Vanguard FTSE Developed Markets ETF
VEA
$173B
| $8.37M | ﹤0.01% |
+213,067
| New | +$8.37M |
|
298
iShares MSCI Germany ETF
EWG
$2.38B
| $8.34M | ﹤0.01% |
290,210
-6,389
| -2% | -$184K |
|
299
Radware
RDWR
$1.09B
| $8.33M | ﹤0.01% |
515,721
-89,309
| -15% | -$1.44M |
|
300
Edwards Lifesciences
EW
$45.9B
| $8.33M | ﹤0.01% |
265,635
-196,158
| -42% | -$6.15M |
|